Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Frater

Showing results (91-100 of 118) with videos related to

Pageof 12
Sort By:
The Journal of Clinical Investigation|January 2, 2025
MHC-related protein 1-restricted recognition of cancer via a semi-invariant TCR-α chainGarry Dolton, Hannah Thomas, Li Rong Tan, et al.
Nature|March 6, 2019
HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantationRavindra K Gupta, Sultan Abdul-Jawad, Laura E McCoy, et al.
Nature Medicine|December 19, 2006
CD8+ T-cell responses to different HIV proteins have discordant associations with viral loadPhotini Kiepiela, Kholiswa Ngumbela, Christina Thobakgale, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 19, 2011
HLA-A*7401-mediated control of HIV viremia is independent of its linkage disequilibrium with HLA-B*5703Philippa C Matthews, Emily Adland, Jennifer Listgarten, et al.
Science (New York, N.Y.)|July 12, 2014
HIV transmission. Selection bias at the heterosexual HIV-1 transmission bottleneckJonathan M Carlson, Malinda Schaefer, Daniela C Monaco, et al.
Science Translational Medicine|September 30, 2016
Nonprogressing HIV-infected children share fundamental immunological features of nonpathogenic SIV infectionMaximilian Muenchhoff, Emily Adland, Owen Karimanzira, et al.
Science Immunology|November 11, 2018
Inhibitory killer cell immunoglobulin-like receptors strengthen CD8<sup>+</sup> T cell-mediated control of HIV-1, HCV, and HTLV-1Lies Boelen, Bisrat Debebe, Marcos Silveira, et al.
Nature Communications|January 21, 2025
Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studiesJesper D Gunst, Jesal Gohil, Johanthan Z Li, et al.
Nature Medicine|May 17, 2016
Impact of pre-adapted HIV transmissionJonathan M Carlson, Victor Y Du, Nico Pfeifer, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Enhanced HIV-1 Control After Antibody Therapy is Associated with Autologous Antibodies and Reservoir Clearance in the RIO trialMarcilio J Fumagalli, Anna Kaczynska, Marius Allombert, et al.
Pageof 12

Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
The Journal of Clinical Investigation|January 2, 2025
MHC-related protein 1-restricted recognition of cancer via a semi-invariant TCR-α chainGarry Dolton, Hannah Thomas, Li Rong Tan, et al.
Nature|March 6, 2019
HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantationRavindra K Gupta, Sultan Abdul-Jawad, Laura E McCoy, et al.
Nature Medicine|December 19, 2006
CD8+ T-cell responses to different HIV proteins have discordant associations with viral loadPhotini Kiepiela, Kholiswa Ngumbela, Christina Thobakgale, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 19, 2011
HLA-A*7401-mediated control of HIV viremia is independent of its linkage disequilibrium with HLA-B*5703Philippa C Matthews, Emily Adland, Jennifer Listgarten, et al.
Science (New York, N.Y.)|July 12, 2014
HIV transmission. Selection bias at the heterosexual HIV-1 transmission bottleneckJonathan M Carlson, Malinda Schaefer, Daniela C Monaco, et al.
Science Translational Medicine|September 30, 2016
Nonprogressing HIV-infected children share fundamental immunological features of nonpathogenic SIV infectionMaximilian Muenchhoff, Emily Adland, Owen Karimanzira, et al.
Science Immunology|November 11, 2018
Inhibitory killer cell immunoglobulin-like receptors strengthen CD8<sup>+</sup> T cell-mediated control of HIV-1, HCV, and HTLV-1Lies Boelen, Bisrat Debebe, Marcos Silveira, et al.
Nature Communications|January 21, 2025
Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studiesJesper D Gunst, Jesal Gohil, Johanthan Z Li, et al.
Nature Medicine|May 17, 2016
Impact of pre-adapted HIV transmissionJonathan M Carlson, Victor Y Du, Nico Pfeifer, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Enhanced HIV-1 Control After Antibody Therapy is Associated with Autologous Antibodies and Reservoir Clearance in the RIO trialMarcilio J Fumagalli, Anna Kaczynska, Marius Allombert, et al.
Pageof 12